Sonendo, Inc. (“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, today reported select preliminary financial results for the year ended December 31, 2025, and other business updates.
Select Financial Updates
On November 17, 2025, Sonendo entered into a strategic collaboration with a European-based dental company and secured exclusive rights to sell high-quality products in North America. This collaboration enables Sonendo to offer a comprehensive suite of endodontic consumable products, complementing its existing portfolio solutions and enhancing its ability to meet the full range of customer needs. The company expects this strategic collaboration to bring significant cost savings to GentleWave customers, drive more demand for the GentleWave Procedure, and support Sonendo’s revenue and gross margin growth.
As the first step of this strategic collaboration, Sonendo launched FlowLogic endodontic files in the first quarter of 2026. Sonendo expects FlowLogic files to compete with the best-performing endodontic files in the industry, while being offered to GentleWave customers at a significant discount.
“I’m pleased to report continued strong execution on our path to profitability. Through disciplined operational improvements, we significantly reduced operating expenses while driving greater efficiencies across the organization. This contributed to a meaningful improvement in our adjusted EBITDA performance. At the same time, we successfully maintained our revenue base, demonstrating the resilience of our core business and the value our GentleWave Procedure continues to deliver to endodontists and their patients. More than 1.9 million patients have been treated with the GentleWave System so far,” said Bjarne Bergheim, President and Chief Executive Officer of Sonendo. “We further strengthened our portfolio by adding high-quality ancillary products. This strategic addition enables us to provide a more complete suite of endodontic consumables, which we believe will substantially lower the cost per root canal procedure for our customers—enhancing their practice economics while expanding our addressable market and supporting long-term revenue growth.”
About Sonendo
Sonendo is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System, when compared to conventional methods of root canal therapy, include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing, and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices.
Source: www.gentlewave.com
News 29 August 2025
Sonendo, Inc., a leading dental technology company and developer of the GentleWave System, announced select financial results for the quarter ended June 30, 2025, and reaffirmed its full-year...
News 13 June 2025
Sonendo, Inc. (“Sonendo” or the “Company”) (OTC Pink: SONX), a leading dental technology company and developer of the GentleWave® System, today reported select financial results for the...
News 08 August 2024
Sonendo announced that it will report financial results for the second quarter of 2024 after the market close on Wednesday, August 7th, 2024.
Sonendo has announced the appointment of John Bostjancic as chief financial officer, the appointment of Robert Guyatt as senior vice president of marketing, and the promotion of John McGaugh to...
Sonendo, Inc., a leading dental technology company and developer of the GentleWave System, has announced that management will present at the upcoming 2024 Stifel Jaws & Paws Conference.
Products 13 May 2026
The OsteoGen Plug® is the original and still the best clinically proven composite grafting plug
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth de
Delta Dental Plan of New Hampshire announces the election of three new members to its board.
Editorials 13 May 2026
Pictured left to right are students Cristina Estrada, JJ DeStefano-Malik and Sophia Chacon.
Oral pathology 13 May 2026
This peer-reviewed oral pathology article summarizes clinical evidence from BMC oral health (2024). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...